Home / Stocks / VALEANT PHARMACEUTICALS INTL
VALEANT PHARMACEUTICALS INTL
2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Holding superinvestors
| Superinvestor | Shares | Value | Weight | Change |
|---|---|---|---|---|
| Pershing Square Capital Management | 21,591,122 | $530.1M | 9.8% | - |
| ValueAct Capital | 14,994,261 | $368.1M | 3.2% | - |
| Davis Advisors | 7,365,210 | $180.8M | 0.8% | Added |
| Miller Value Partners | 2,291,400 | $56.25M | 3.2% | Added |
| Chou Associates | 1,446,843 | $35.52M | 13.4% | - |
| First Eagle Investment Management | 380,900 | $9.351M | 0.0% | - |
By quarter
| Quarter | Holders | Total value |
|---|---|---|
| 2013-06-30 | 8 | $4.05B |
| 2013-09-30 | 7 | $4.725B |
| 2013-12-31 | 8 | $5.354B |
| 2014-03-31 | 9 | $6.66B |
| 2014-06-30 | 8 | $6.968B |
| 2014-09-30 | 8 | $7.245B |
| 2014-12-31 | 8 | $7.347B |
| 2015-03-31 | 10 | $11.87B |
| 2015-06-30 | 10 | $12.11B |
| 2015-09-30 | 10 | $10.1B |
| 2015-12-31 | 8 | $5.795B |
| 2016-03-31 | 8 | $1.338B |
| 2016-06-30 | 6 | $961.2M |
| 2016-09-30 | 6 | $1.18B |
| 2016-12-31 | 6 | $690.3M |
| 2017-03-31 | 5 | $337.4M |
| 2017-06-30 | 4 | $495.2M |
| 2017-09-30 | 5 | $412.3M |
| 2017-12-31 | 4 | $526.6M |
| 2018-03-31 | 4 | $409.3M |
| 2018-06-30 | 4 | $581.2M |